Home On TV & Video Video Advertising Can Work For Pharma And Healthcare Brands – But There Are Nuances To Keep In Mind

Video Advertising Can Work For Pharma And Healthcare Brands – But There Are Nuances To Keep In Mind

SHARE:

On TV & Video” is a column exploring opportunities and challenges in advanced TV and video. 

Today’s column is by Kelly McAloon, associate media director of programmatic at Good Apple.

Pharma’s digital transformation has accelerated media spending on video across devices. Both vertical and video spending in the healthcare and pharma sectors are expected to increase YoY by 11% and 19%, respectively. With shifting media consumption habits, media buyers are testing and experimenting with different combinations to maintain visibility and engage key audiences. It’s trial and error.

But media buyers in the pharma space have the additional challenge of needing to adhere to numerous regulations, including required disclaimers and clickouts embedded in assets.

In a space where every campaign requires precise targeting and numerous legal considerations, adhering to the four-part framework below can maximize engagement and efficiency.

Create platform-agnostic assets

No matter the vertical, short-form videos allow for better scale and more efficient performance. More specifically, assets under 60 seconds have the most available inventory. But running a short-form video can be difficult for pharma, particularly for prescription brands requiring disclaimers that interfere with length. 

QR codes or customized CTAs can be effective work-arounds that encourage users to visit the site while still making room for important safety information on-screen. If only one video asset is available, use the highest common denominator specs to create a video that will work across multiple screens.

Well-rounded reach across patients and physicians can be achieved with a mix of CTV and non-CTV (mobile/desktop/tablet). CTV’s one-to-many medium is best suited for reaching patients, but technical advancements will soon enable more precise targeting for healthcare providers across TV screens as well. Longer-form videos, meanwhile, can work well for non-CTV channels.

Consider video-first ad servers

Long-form videos often need to be VPAID-compatible since they require clickouts and brand-safety blocking tags. Audit ad server video capabilities to determine whether VPAID assets with multiple clickouts can function properly.

Be smart about the targeting

Precise, condition-based targeting in pharma advertising is essential. But patients are more than their condition. Advertisers need to consider other signals. 

Not every partner can ingest health data segments, and although they’re an integral part of any pharma campaign, they tend not to be as efficient. In order to combat this and maintain a well-rounded targeting strategy, use segments based on TV viewership, social media shares and other lifestyle-related inputs.  

Subscribe

AdExchanger Daily

Get our editors’ roundup delivered to your inbox every weekday.

Prep for the cookieless future now, even though deprecation has been delayed. Verify that providers are using privacy-safe, opted-in audience sources that rely on alternate forms of identifiers and a healthy mix of data types (second party, zero party and/or first party).

Tailor measurement to individual campaigns

The disclaimer language that comes with branded pharma videos reduces the likelihood of a consumer watching the entire video. If completed views are the priority KPI, opt for non-skippable and CTV environments. 

The length of the asset and unique campaign goals can determine which metrics are the best indicators of performance. Maybe the KPI shouldn’t be a completed view, but instead a view through key brand messaging.

Video advertising may be tougher for pharma and healthcare than for other industries, but it’s equally promising – and ripe with opportunity. Don’t be afraid to experiment with various channels to find the right mix.

Follow Good Apple (@GoodApple_) and AdExchanger (@adexchanger) on Twitter.

Must Read

Conversion APIs Are Becoming Table Stakes – But Not All Brands Have Bought In

CAPI integrations have moved from a nice-to-have to a necessity for anyone operating within walled garden environments. Now they’re laying the groundwork for an outcomes-driven ad ecosystem.

Peppa Pig

The Media And Retail Deals Behind The Peppa Pig Franchise Expansion

Peppa Pig is everywhere. Whether or not you have children, you likely know the little girl pig from the kid’s cartoon show. But the Peppa media franchise is just getting started.

How A For-Profit College Is Using CTV Ads To Win Over New Students

The American College of Education partnered with performance TV company MNTN to better reach its audience of adults seeking higher education.

Privacy! Commerce! Connected TV! Read all about it. Subscribe to AdExchanger Newsletters

Critics Say The Trade Desk Is Forcing Kokai Adoption, But Apparently It’s Up To Agencies

Is TTD forcing agencies to adopt the new Kokai interface despite claims they can still use the interface of their choice? Here’s what we were able to find out.

Why Big Brand Price Increases Will Flatten Ad Budgets

Product prices and marketing budgets are flip sides of the same coin. But the phase-in effects of tariffs, combined with vicissitudes of global weather and commodity production, challenge that truism.

The IAB Tech Lab Isn’t Pulling Any Punches In The Fight Against AI Scraping

IAB Tech Lab CEO Anthony Katsur didn’t mince his words when declaring unauthorized generative AI scraping of publisher content “theft, full stop.”